Eric Laub | Vice President-Investor Relations |
Richard Murray | Chief Executive Officer and President |
Hugh Cole | Chief Operating Officer |
Elizabeth Trehu | Chief Medical Officer |
Dmitri Wiederschain | Chief Scientific Officer |
Kim Drapkin | Chief Financial Officer |
Steven Seedhouse | Raymond James |
Boris Peaker | Cowen and Company |
Edward Tenthoff | Piper Sandler |
David Dai | SMBC Nikko |
Yu He | H.C. Wainwright & Co. |
Colleen Kusy | Robert W. Baird |
Good morning, ladies and gentlemen, and welcome to the Jounce Therapeutics Third Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduction a question-and-answer session and instructions will follow at that time.
As a reminder, this call is being recorded at the company's request. I will now turn the call over to your host, Eric Laub with Jounce Therapeutics.